FDA Letter API

Lakeview Dairy, LLC

Letter data

Company
Lakeview Dairy, LLC
Recipient
Michael D. Roecker, Bruce G. Walker | Co-owners | Lakeview Dairy, LLC | Mayville Animal Clinic S.C., White Diamond Dairy, LLC | N8783 Basswood Road | Beaver Dam | , | WI | 53916-9352 | United States
Issue date
2019-05-30
Posted date
Not available
FDA office
Center for Veterinary Medicine
Subject
Not available
Product
Animal & Veterinary
CMS ID
565303
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Lakeview Dairy, LLC MARCS-CMS 565303 — May 30, 2019 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Animal & Veterinary Recipient: Recipient Name Michael D. Roecker, Bruce G. Walker Recipient Title Co-owners Lakeview Dairy, LLC Mayville Animal Clinic S.C., White Diamond Dairy, LLC N8783 Basswood Road Beaver Dam , WI 53916-9352 United States Issuing Office: Center for Veterinary Medicine 250 Marquette Avenue Suite 600 Minneapolis , MN 55401 United States 612) 334-4100 Dear Messrs. Roecker and Walker: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter CMS 565303 dated October 19, 2018. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Dianna C. Sonnenburg Compliance Officer, West Division 1 - CB Office of Human and Animal Foods Operations Content current as of: 06/10/2019 Regulated Product(s) Animal & Veterinary